XLP
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) (NCT05005975) | Tanabe Pharma America, Inc. | 2021-08-10 |
| Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria (NCT04402489) | Tanabe Pharma America, Inc. | 2020-06-01 |
| Oral Iron for Erythropoietic Protoporphyrias (NCT02979249) | Icahn School of Medicine at Mount Sinai | 2016-12-01 |
| Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact (NCT01688895) | Icahn School of Medicine at Mount Sinai | 2012-07-01 |
Track XLP automatically
Every clearance here is in the API, with alerts when new ones post.